RecallDepth
Class II Ongoing

Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.

This recall is currently active, issued May 7, 2025. It was issued by Cardinal Health Inc..

Company
Cardinal Health Inc.
Recall Initiated
April 9, 2025
Posted
May 7, 2025
Recall Number
D-0393-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
48 Cartons
Firm Location
Dublin, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Distribution

NC, SC, VA

Lot / Code Info

Lot PZFDE06, Exp 08/31/2025

More recalls by Cardinal Health Inc.

View all recalls by this company →

Other recent Class II Drug recalls